Calquence(acalabrutinib) is a second-generation, selective inhibitor of Bruton's tyrosine kinase (BTK).Calquencebinds covalently to BTK, thereby inhibiting its activity.9In B-cells, BTK signalling results in activation of pathways necessary for B-cell proliferation, trafficking, chemotaxis and adhesion...